SPAC Feed

La téléphonique de bureau continue de se positionner comme l’un des principaux vecteurs de communication entre les professionnels. Dans ce contexte, la téléphonie sur IP est désormais le partenaire de communication de la majorité des structures publiques ou privées. Cela s’explique notamment par la maturité des offres du marché et par leur ouverture vers le système d’information. C’est par exemple le cas avec l’intégration des solutions CRM ou l’utilisation exponentielle des solutions de communication unifiée. Mais une nouvelle tendance est aujourd’hui largement répandue sur le secteur de la téléphonie IP : la cybersécurité et l’intelligence artificielle.

FORM 8.3

U.S. THF Market to Reach USD 2.07 Billion by 2035; Europe Market Projected to Reach USD 2.10 Billion as Pharmaceutical, Polymer and Sustainable Chemical Applications Expand

U.S. THF Market to Reach USD 2.07 Billion by 2035; Europe Market Projected to Reach USD 2.10 Billion as Pharmaceutical, Polymer and Sustainable Chemical Applications Expand

DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) —

AI-Native Architecture Redefines Quantitative Trading Standards as Human-AI Risk Management Strengthens the Compliance Framework.

DUBAI, United Arab Emirates, Sept. 08, 2026 (GLOBE NEWSWIRE) —

Ninth edition proceeds as planned, bringing the industry together as the sector moves through a period of rapid platform and technology change.

London, UK – 8 September 2026: GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, today announced that it has appointed Vivid Sehgal as Operating Partner.

The platform combines advanced detection, investigation and management capabilities into a single modular solution, helping insurers detect, investigate and disrupt fraud with tools tailored to their unique risk profiles.

The platform combines advanced detection, investigation and management capabilities into a single modular solution, helping insurers detect, investigate and disrupt fraud with tools tailored to their unique risk profiles.

Vancouver, BC, Canada, Sept. 08, 2026 (GLOBE NEWSWIRE) — Global Power Solutions Corp. (TSX Venture Exchange: PWER; Frankfurt Stock Exchanges: NJA) (“Global Power” or the “Company”) is pleased to announce the appointment of Lyle McChesney as a Strategic Advisor to the Company.

Mr. McChesney brings extensive mechanical, electrical, hydraulic, equipment maintenance, and industrial systems experience to Global Power Solutions. His hands-on technical background and ability to diagnose, repair, and maintain complex mechanical and electrical systems will provide valuable practical expertise as the Company advances its energy and infrastructure initiatives.

Mr. McChesney has extensive experience working with mechanical equipment, outboards, power systems, hydraulic and steering systems, electrical components, plumbing and fluid systems, and engine-driven equipment. His experience also includes parts and inventory management, record keeping, equipment maintenance, troubleshooting, and ensuring operational safety.

Mr. McChesney’s broad technical background complements Global Power Solutions’ focus on developing and implementing innovative, scalable power-generation and infrastructure technologies. His practical understanding of machinery, fluid systems, hydraulics, electrical systems, and equipment reliability will support the Company’s efforts to evaluate, develop, and deploy next-generation energy solutions.

“Lyle brings an important practical and technical perspective to Global Power Solutions,” said Peter Medved, Chief Executive Officer. “His extensive experience diagnosing and maintaining complex mechanical systems will complement our engineering and technology development efforts and help ensure that our solutions remain grounded in real-world operational requirements.”

Mr. McChesney stated, “I am pleased to join Global Power Solutions as a Strategic Advisor. I look forward to contributing my mechanical and technical experience to the Company’s innovative approach to power generation and infrastructure solutions.”

About Global Power Solutions Corp.

Global Power Solutions Corp. is expanding its business strategy to become a provider of innovative clean energy infrastructure designed to support the rapidly growing power requirements of AI data centres and mission-critical facilities. The Company is focused on developing hydrogen-enabled baseload power solutions that provide reliable, scalable and sustainable energy where traditional grid infrastructure is constrained or unavailable. In addition, Global continues its established operations in the manufacture of light gauge steel components and modular building systems for the construction industry.

We seek Safe Harbor.

On behalf of the Board:
Global Power Solutions Corp.

“Peter Medved “
CEO
Tel: 604.684.2181 | Email: info@globalpowercorp.com | https://globalpowercorp.com/

Wim Vanderaerden Named Operations Director; Bert Van Peteghem Joins as Quality Director and Qualified Person

Wim Vanderaerden Named Operations Director; Bert Van Peteghem Joins as Quality Director and Qualified Person

Nokia’s Mobile Core Early Access offers a practical, hands-on way to explore the latest mobile core capabilities and use cases.

Machine Identity Security Market is Segmented by Offering, Identity Type, Deployment, Application, Organization Size, End-Use Industry and Region 2026-2035

ASML and TSMC Announce Initiative to Pioneer Industry Transition to Large-Format Photomasks for High NA EUV

ANTWERP, Belgium, 8 September 2026, 08:00 a.m. CET – CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) (NYSE: CMBT, Euronext Brussels: CMBT en Euronext Oslo Børs: CMBTO) invites its shareholders to participate in the Special General Meeting that will be held on Thursday 8 October 2026.

Alderley Park, Cheshire, U.K. – 8 September 2026 – Infex Therapeutics, a leading anti-infectives specialist, today announced new data from its Phase IIa study of RESP-X (INFEX702), a first-in-class anti-virulence monoclonal antibody, in non-cystic fibrosis bronchiectasis (NCFB) patients colonised with Pseudomonas aeruginosa (Pa), which will be presented in a late-breaking poster abstract at the European Respiratory Society (ERS) Congress 2026 at 12:30-14:00 CEST in Barcelona, Spain.

Alderley Park, Cheshire, U.K. – 8 September 2026 – Infex Therapeutics, a leading anti-infectives specialist, today announced new data from its Phase IIa study of RESP-X (INFEX702), a first-in-class anti-virulence monoclonal antibody, in non-cystic fibrosis bronchiectasis (NCFB) patients colonised with Pseudomonas aeruginosa (Pa), which will be presented in a late-breaking poster abstract at the European Respiratory Society (ERS) Congress 2026 at 12:30-14:00 CEST in Barcelona, Spain.

Aktsiaseltsi Infortar tütarühing OÜ Infortar Agro (edaspidi Infortar Agro) ning AB „Invalda INVL“ kaudselt UAB Cedus Invest kaudu, Gintaras Kateiva ja Adomas Grigaitis (edaspidi ühiselt „Müüja“) sõlmisid 7. septembril 2026 lepingu, mille kohaselt omandab Infortar Agro 100% Leedu äriühingu UAB Litagra (Litagra) osadest.

Aktsiaselts Infortar subsidiary OÜ Infortar Agro (hereinafter “Infortar Agro”) and AB Invalda INVL indirectly through UAB Cedus Invest, Gintaras Kateiva and Adomas Grigaitis (hereinafter the “Seller”) entered into an agreement on 7 September 2026, in which the Seller will sell to Infortar Agro 100% of the shares in its Lithuanian subsidiary UAB Litagra (“Litagra”).

Firm completes second acquisition since launch, growing portfolio to 22 units and approximately $5 million in assets under management

Firm completes second acquisition since launch, growing portfolio to 22 units and approximately $5 million in assets under management

NEW YORK, NY, Sept. 07, 2026 (GLOBE NEWSWIRE) — The Global Healthcare Leaders Foundation (GHLF) marked an important new chapter this month, recognizing 16 exceptional healthcare leaders over the course of two weeks while expanding its executive leadership, strategic partnerships, and national mission.

U.S. Radioligand Therapy Market to Reach USD 10.68 Billion and Europe USD 1.79 Billion by 2035 as PSMA-Targeted Therapies, Alpha-Emitter Innovation, and Expanding Isotope Production Drive Demand.

U.S. Radioligand Therapy Market to Reach USD 10.68 Billion and Europe USD 1.79 Billion by 2035 as PSMA-Targeted Therapies, Alpha-Emitter Innovation, and Expanding Isotope Production Drive Demand.